Dietary supplementation of β-guanidinopropionic acid (βGPA) reduces whole-body and skeletal muscle growth in young CD-1 mice

@article{Baumgarner2015DietarySO,
  title={Dietary supplementation of β-guanidinopropionic acid (βGPA) reduces whole-body and skeletal muscle growth in young CD-1 mice},
  author={Bradley L. Baumgarner and Alison M. Nagle and Meagan R. Quinn and A. Elaine Farmer and Stephen T. Kinsey},
  journal={Molecular and Cellular Biochemistry},
  year={2015},
  volume={403},
  pages={277-285}
}
Increased AMP-activated protein kinase (AMPK) activity leads to enhanced fatty acid utilization, while also promoting increased ubiquitin-dependent proteolysis (UDP) in mammalian skeletal muscle. β-guanidinopropionic acid (βGPA) is a commercially available dietary supplement that has been shown to promote an AMPK-dependent increase in fatty acid utilization… CONTINUE READING